Cyient working capital

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

285.38×	285.38×	167.80×	170.71×	187.32×	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
68.10×	68.10×	—	61.00×	56.44×
173.86×	173.86×	144.62×	264.93×	374.33×
179.62×	179.62×	—	−33.22×	−130.57×
2.66×	2.37×	—	3.76×	5.15×
0.91×	0.91×	—	1.05×	1.06×
1.70×	1.70×	—	1.03×	1.08×
0.86×	0.86×	—	0.56×	0.55×

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

CYIENT₹1,225.80

Cyient Ltd.

· Technology

₹ CrorePeersLTTS TATAELXSI KPITTECH BSOFT INTELLECT ZENSARTECH LATENTVIEW MAPMYINDIAMcap ₹13,631 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Inventory Days (DIO)	187.32	170.71	167.80	285.38	285.38
Receivable Days (DSO)	56.44	61.00	—	68.10	68.10
Payable Days (DPO)	374.33	264.93	144.62	173.86	173.86
Cash Conversion Cycle (days)	-130.57	-33.22	—	179.62	179.62
Working Capital Turnover	5.15	3.76	—	2.37	2.66
Asset Turnover	1.06	1.05	—	0.91	0.91
Cash Conversion (CFO/Net Income)	1.08	1.03	—	1.70	1.70
CFO/EBITDA	0.55	0.56	—	0.86	0.86

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.